Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan
· Delayed Price · Currency is TWD 26.50
+0.15 (0.57%)
Apr 29, 2026, 1:30 PM CST
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 5.88 billion as of April 28, 2026. Its market cap has decreased by -25.14% in one year.
Market Cap
5.88B
Enterprise Value
5.45B
Revenue
1.40B
Ranking
n/a
PE Ratio
29.13
Stock Price
26.50
Market Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 5.88B, an increase of 42.78%. That is a compound annual growth rate of 2.60%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 5.71B |
| LIWANLI Innovation | 6.30B |
| Formosa Laboratories | 6.42B |
| Easywell Biomedicals | 4.87B |
| Orient EuroPharma | 4.03B |
| Merdury Biopharmaceutical | 3.52B |
| Alar Pharmaceuticals | 10.19B |
| Standard Chemical & Pharmaceutical | 10.94B |